• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.

作者信息

Morgan S H, Rudge P, Smith S J, Bronstein A M, Kendall B E, Holly E, Young E P, Crawfurd M D, Bannister R

机构信息

Division of Inherited Metabolic Diseases, MRC Clinical Research Centre, Harrow, Middlesex.

出版信息

Q J Med. 1990 May;75(277):491-507.

PMID:2167495
Abstract

Anderson-Fabry disease is an X-linked inborn error of metabolism characterized by subnormal activity of the lysosomal hydrolase, alpha-galactosidase A. We have assessed the incidence and nature of neuropathy in 12 patients (seven affected men and five carrier females). Abnormalities of cutaneous thermal sensation were common, even in asymptomatic carriers, with a unique predilection for cold sensitivity which suggests involvement of small myelinated nerve fibres. Intracranial abnormalities were frequently detected by magnetic resonance imaging (MRI) in males, both with and without overt cerebrovascular disease, and were more extensive in older patients. Such abnormalities were not detected in carriers. Auditory and vestibular abnormalities were present in six patients, only one of whom was symptomatic. Cranial MRI and assessment of cutaneous thermal thresholds are sensitive techniques which can identify neurological involvement in asymptomatic patients. They may be of benefit in monitoring the effectiveness of enzyme replacement therapy and excluding the carrier state for the defective gene.

摘要

相似文献

1
The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.
Q J Med. 1990 May;75(277):491-507.
2
Anderson-Fabry disease with cerebrovascular complications in two Italian families.两个意大利家族中伴有脑血管并发症的安德森-法布里病
Neurol Sci. 2002 Jun;23(2):49-53. doi: 10.1007/s100720200025.
3
Heterozygote detection in Fabry disease utilizing multiple enzyme activities.利用多种酶活性检测法布里病杂合子。
Am J Med Genet. 1981;10(2):141-6. doi: 10.1002/ajmg.1320100207.
4
Chiari type I malformation in four unrelated patients affected with Fabry disease.
Eur J Med Genet. 2006 Sep-Oct;49(5):419-25. doi: 10.1016/j.ejmg.2006.01.007. Epub 2006 Feb 9.
5
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.法布里病杂合子患者的神经纤维功能和结构研究结果
Pain. 2009 Sep;145(1-2):237-45. doi: 10.1016/j.pain.2009.06.032. Epub 2009 Aug 7.
6
Clinical spectrum of Anderson Fabry disease in a Romanian family.罗马尼亚一个家族中安德森法布里病的临床谱
Rom J Intern Med. 2006;44(2):201-10.
7
Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.法布里病:半合子和杂合子患者皮肤的超微结构比较研究
Acta Neuropathol. 2006 Feb;111(2):178-85. doi: 10.1007/s00401-005-0026-8. Epub 2006 Feb 7.
8
[Biochemical diagnosis of Anderson-Fabry disease in two brothers].[两兄弟中安德森-法布里病的生化诊断]
Vopr Med Khim. 1986 Sep-Oct;32(5):120-3.
9
Disease manifestations and X inactivation in heterozygous females with Fabry disease.法布里病杂合子女性的疾病表现与X染色体失活
Acta Paediatr Suppl. 2006 Apr;95(451):30-8. doi: 10.1111/j.1651-2227.2006.tb02386.x.
10
Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.法布里病:新型α-半乳糖苷酶A突变的鉴定及通过荧光化学错配切割进行分子携带者检测
Biochem Biophys Res Commun. 1999 Apr 21;257(3):708-13. doi: 10.1006/bbrc.1999.0310.

引用本文的文献

1
Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.安德森-法布里病的发病机制和分子机制及可能的新分子靶向治疗策略。
Int J Mol Sci. 2021 Sep 18;22(18):10088. doi: 10.3390/ijms221810088.
2
Inhibition of Mitochondrial Complex I Impairs Release of α-Galactosidase by Jurkat Cells.线粒体复合物 I 的抑制作用可损害 Jurkat 细胞释放α-半乳糖苷酶。
Int J Mol Sci. 2019 Sep 5;20(18):4349. doi: 10.3390/ijms20184349.
3
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation.
N215S 突变所致晚发型法布瑞病的表型和生化异质性。
PLoS One. 2018 Apr 5;13(4):e0193550. doi: 10.1371/journal.pone.0193550. eCollection 2018.
4
Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease.法布里病中的神经耳科学和周围神经受累情况
Audiol Res. 2017 Jul 28;7(2):176. doi: 10.4081/audiores.2017.176. eCollection 2017 Jul 18.
5
Electroneuromyographic Features in Fabry Disease: A Retrospective Review.法布里病的神经电生理特征:一项回顾性研究。
Noro Psikiyatr Ars. 2015 Sep;52(3):258-262. doi: 10.5152/npa.2015.7646. Epub 2015 Jul 7.
6
Fabry disease: a rare cause of neuropathic pain.法布里病:一种导致神经病理性疼痛的罕见病因。
Curr Pain Headache Rep. 2013 Oct;17(10):365. doi: 10.1007/s11916-013-0365-4.
7
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.早期诊断法布里病的周围神经系统受累和治疗神经病理性疼痛:专家小组报告。
BMC Neurol. 2011 May 27;11:61. doi: 10.1186/1471-2377-11-61.
8
Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests.法布瑞病的自主神经病变:前瞻性研究采用自主症状谱和心血管自主功能测试。
BMC Neurol. 2010 Jun 7;10:38. doi: 10.1186/1471-2377-10-38.
9
Fabry disease in children and the effects of enzyme replacement treatment.儿童法布里病及酶替代疗法的效果
Eur J Pediatr. 2009 Nov;168(11):1355-63. doi: 10.1007/s00431-009-0937-9. Epub 2009 Feb 26.
10
Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy.
J Neurol. 2007 Oct;254(10):1433-42. doi: 10.1007/s00415-007-0575-y. Epub 2007 Oct 15.